144 related articles for article (PubMed ID: 38146764)
1. Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline MK; Caram MEV; Shahinian VB; Hollenbeck BK
Cancer; 2024 May; 130(9):1609-1617. PubMed ID: 38146764
[TBL] [Abstract][Full Text] [Related]
2. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
[TBL] [Abstract][Full Text] [Related]
3. Urologists' use of intensity-modulated radiation therapy for prostate cancer.
Mitchell JM
N Engl J Med; 2013 Oct; 369(17):1629-37. PubMed ID: 24152262
[TBL] [Abstract][Full Text] [Related]
4. Urologist Practice Structure and Spending for Prostate Cancer Care.
Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
[TBL] [Abstract][Full Text] [Related]
5. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
[TBL] [Abstract][Full Text] [Related]
6. Documenting Horizontal Integration Among Urologists Who Treat Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care Res Rev; 2022 Feb; 79(1):141-150. PubMed ID: 33331217
[TBL] [Abstract][Full Text] [Related]
7. Health care delivery system contributions to management of newly diagnosed prostate cancer.
Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
[TBL] [Abstract][Full Text] [Related]
8. Urologist practice structure and quality of prostate cancer care.
Modi PK; Yan P; Hollenbeck BK; Kaufman SR; Borza T; Skolarus TA; Schroeck FR; Ryan AM; Shahinian VB; Herrel LA
Urol Pract; 2020 Sep; 7(5):419-424. PubMed ID: 34541260
[TBL] [Abstract][Full Text] [Related]
9. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline M; Caram MEV; Shahinian VB; Hollenbeck BK
Cancer Med; 2023 Dec; 12(24):22325-22332. PubMed ID: 38100144
[TBL] [Abstract][Full Text] [Related]
10. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
Maganty A; Hollenbeck BK; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB
Urology; 2023 Jul; 177():95-102. PubMed ID: 37146728
[TBL] [Abstract][Full Text] [Related]
11. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK
Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652
[TBL] [Abstract][Full Text] [Related]
12. Association between urology practice use of multiparametric MRI and genomic testing and treatment of men with newly diagnosed prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Oerline MK; Maganty A; Shahinian VB; Hollenbeck BK
Urol Oncol; 2023 Oct; 41(10):430.e17-430.e23. PubMed ID: 37580226
[TBL] [Abstract][Full Text] [Related]
13. Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.
Shahinian VB; Kaufman SR; Yan P; Herrel LA; Borza T; Hollenbeck BK
Medicine (Baltimore); 2017 Jun; 96(25):e6929. PubMed ID: 28640073
[TBL] [Abstract][Full Text] [Related]
14. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.
Modi PK; Kaufman SR; Borza T; Yan P; Miller DC; Skolarus TA; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
Cancer; 2018 Aug; 124(16):3364-3371. PubMed ID: 29905943
[TBL] [Abstract][Full Text] [Related]
15. Association Between Urologist Merit-Based Incentive Payment System Performance and Quality of Prostate Cancer Care.
Maganty A; Kaufman SR; Oerline MK; Faraj K; Caram MEV; Shahinian VB; Hollenbeck BK
Urol Pract; 2024 Jan; 11(1):207-214. PubMed ID: 37748132
[TBL] [Abstract][Full Text] [Related]
16. Impact of urologists' ownership of radiation equipment in the treatment of prostate cancer.
Williams SB; Huo J; Chapin BF; Smith BD; Hoffman KE
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):300-304. PubMed ID: 28349981
[TBL] [Abstract][Full Text] [Related]
17. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
18. Medicare fee reductions and the overuse of intensity-modulated radiotherapy.
Howard DH; Hockenberry J
Health Serv Res; 2021 Aug; 56(4):626-634. PubMed ID: 33905136
[TBL] [Abstract][Full Text] [Related]
19. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
[TBL] [Abstract][Full Text] [Related]
20. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]